A8536332
N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide , 95% , 302964-08-5
CAS NO.:302964-08-5
Empirical Formula: C16H13Cl2N5OS
Molecular Weight: 394.28
MDL number: MFCD11045075
EINECS: 695-686-7
| Pack Size | Price | Stock | Quantity |
| 1G | RMB52.80 | In Stock |
|
| 5G | RMB184.80 | In Stock |
|
| 25g | RMB516.00 | In Stock |
|
| 100g | RMB1703.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 333-335°C |
| Boiling point: | 566.95° C (Predicted) |
| Density | 1.516±0.06 g/cm3(Predicted) |
| refractive index | n20D 1.72 (Predicted) |
| storage temp. | Inert atmosphere,2-8°C |
| solubility | DMSO (Slightly) |
| pka | 10.92±0.70(Predicted) |
| form | Solid |
| color | Pale Yellow |
| Water Solubility | Slightly soluble in water |
| InChI | InChI=1S/C16H13Cl2N5OS/c1-8-4-3-5-10(17)14(8)23-15(24)11-7-19-16(25-11)22-13-6-12(18)20-9(2)21-13/h3-7H,1-2H3,(H,23,24)(H,19,20,21,22) |
| InChIKey | LMXUWARKUIELGT-UHFFFAOYSA-N |
| SMILES | S1C(C(NC2=C(C)C=CC=C2Cl)=O)=CN=C1NC1C=C(Cl)N=C(C)N=1 |
| CAS DataBase Reference | 302964-08-5(CAS DataBase Reference) |
Description and Uses
N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide is a pharmaceutical intermediate compound used as a synthetic intermediate for dasatinib. Dasatinib is a targeted anticancer drug used to treat chronic myeloid leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (ALL). It is also a receptor and non-receptor Tyk (tyrosine kinase) inhibitor, which plays an important role in certain cancers and fibrotic diseases.
Dasatinib intermediate. A protein tyrosine kinase inhibitor.
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319 |
| Precautionary statements | P261-P305+P351+P338 |
| HS Code | 2933399990 |

![N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide](https://img.chemicalbook.com/CAS/GIF/302964-08-5.gif)



